EW News and Press, Edwards Lifesciences Corporation From 04/16/21

Zynex is well positioned to capitalize on recent fundamental momentum in sales volume and top-line growth. Such momentum hasn't yet translated to share performance, and the market continues to discount Zynex shares. Questions around management's posture on inventory remain, and la...

When influential investors make decisions to buy and sell securities, they normally want to keep it quiet.  However, if we pay close attention we can see what is going on, and make good decisions.. The Edwards Lifesciences (NYSE: EW) report below can help you understand how to do t...

Edwards Lifesciences To Host Earnings Conference Call On April 20, 2021 PR Newswire IRVINE, Calif. , April 13, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2021 after the market c...

Edwards Lifesciences has shown consistent earnings and revenue growth in the last few years and it has strong profitability measurements. The company is scheduled to report first quarter earnings results on April 20 with earnings expected to decline slightly from Q1 2020. Sentimen...

Edwards Lifesciences is a global leader of patient-focused medical innovations for structural heart disease as well as critical care monitoring. The company not only can expect high growth rates in the years to come, it also has a wide economic moat around its business. But right ...

Edwards Lifesciences ([[EW]] +2.1%) is continuing its 10-day winning streak after Evercore ISI upgraded the stock to outperform from in-line.Noting a ‘meaningful discount’ compared to peers such as Intuitive Surgical ([[ISRG]] +2.4%) and Illumina ([[ILMN]] -0.1%) the analyst Vij...

Traditionally Wall Street has used fundamental analysis to make investment decisions in stocks like Edwards Lifesciences (NYSE: EW) but sometimes the most revealing aspect of the fundamental health of a company can be found through an observation of its price action.  Price action ...

Investors in Edwards Lifesciences (NYSE: EW) like to make good decisions, that means they like to buy and sell at the right times, and to do that the best tools involve charts, pivot points, and the technical data.  Below, we have provided a snapshot for EW that reveals this i...

Technical analysis provides insights that fundamental observations cannot.  We can use that to our advantage in Edwards Lifesciences (NYSE: EW).   Using the data offered below we have a real-time example.  Review The technical data for EW below, and the added value o...

This Edwards Lifesciences (NYSE: EW) report helps investors and traders identify both opportunity, and potential red flags, by using the price action of the stock.  The trading plans for EW have risk controls, and that make these observations both opportunistic and defensive, but t...